Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Rosetta to acquire minority stake in Karolinska
As part of the transaction, the company will transfer 13 of its portfolio company holdings to a new private holding company, KDev Investments, which will include portfolio of
As part of the transaction, the company will transfer 13 of its portfolio company holdings to a new private holding company, KDev Investments, which will include portfolio of
Omni Bio is involved in developing alternative uses of Alpha-1 antitrypsin (AAT), designed for treating various indications, as well as recombinant forms of AAT. Prior to joining the
Solithromycin, the company’s fluoroketolide antibiotic candidate, is designed for treating patients with community-acquired bacterial pneumonia (CABP). The study, which will enroll approximately 800 patients with PORT-II to PORT-IV
HPA seasonal flu surveillance head Richard Pebody said HPA is seeing an increase in flu activity mainly among school children indicating the start of this year’s flu season.
To manage the rising number of pertussis cases, Synthetic Biologics intends to decrease the mortality rate in infants as well as to decrease the chronic cough in adults
Meningitec is an established commercial vaccine to prevent invasive disease caused by Neisseria meningitidis serogroup C. Nuron will also use the funds for clinical development of its new
In early 2012, Dendreon had decided to bring down Provenge production at the facility as part of its strategic restructuring plan to increase profitability and future growth. Dendreon
BIGHEALTHr solution, which comes with built-in ontologies, can be configured to collect big data from social media, videos, scholar publications, clinical trials, FDA, Wikipedia, mobile apps, product reviews,
As part of the alliance, the companies will conduct data-driven collaborative research to leverage Humedica’s experience to gather and normalise de-identified healthcare data from disparate systems and Pfizer’s
US FDA has granted Investigational New Drug (IND) status to Lisinopril, which allows TLS to conduct phase 2a study to know the effects of the drug, used to